drugset
drugset / Trial / NCT02088892

A Clinical Challenge Study of BCG in Healthy Volunteers

NCT02088892 ↗

Completed 52 enrolled University of Oxford Aeras · collabUniversity of Birmingham · collab
Non-randomizedParallel-groupOpen-label

Summary

TB031 is a challenge study comparing two different strains of the Bacille Calmette-Guérin (BCG) vaccine at standard and high dose.

Timeline

Start
2014-03
Primary completion
2015-01
Completion
2015-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject BCG SSI Vaccine 200000 unknown Other
Subject BCG SSI Vaccine 600000 unknown Other
Subject BCG SSI Vaccine 800000 unknown Other
Subject BCG SSI Vaccine 2.4e+06 unknown Other
Subject BCG Tice Vaccine 200000 unknown Other
Subject BCG Tice Vaccine 600000 unknown Other
Subject BCG Tice Vaccine 800000 unknown Other
Subject BCG Tice Vaccine 2.4e+06 unknown Other

Indications

tuberculosis